Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma.

Cancers (Basel) · 2025 · PMC11815779 · PMID 39941802

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a favorable trendp = 0.12not close (p > 0.1)

A favorable trend was also observed for ORR (52.5% vs. 35.1%, p = 0.12) and OS (20.0 vs. 8.8 months; HR: 0.62; 95% CI: 0.35–1.10; p = 0.10) ( Figure 3 B).

also in 313 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.